Illustration: Sarah Grillo/Axios
Early stage venture firm Genoa Ventures is preparing to raise $100 million this year for its third fund.
Why it matters: Genoa invests in biotech startups in agriculture, food, tools and diagnostics, and industrials like chemicals.
